CFDE Data Portal | Search GPC6-AS1

	Label	Description
	GPC6-AS1 associations Collection (Entity type)	Associations for GPC6-AS1_associations
	GPC6-AS1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GPC6-AS1 Gene (Entity type)	ENSG00000236520 - GPC6 antisense RNA 1
	GSE128730 3 V 5 NERATINIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 12 V 0 NICOTINAMIDE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE195663 cisplatin 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE132369,GSE132371 3 V 0 CCCP HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE164874 5 V 10 PREDNISOLONE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE120210 GSE120214 TBXT brachyury inhibition 4 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE116810 5 V 1 SELINEXOR HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

GPC6-AS1 associations

Associations for GPC6-AS1_associations

GPC6-AS1 associations.tsv

A file from IDG as part of the Harmonizome project

GPC6-AS1

ENSG00000236520 - GPC6 antisense RNA 1

GSE128730 3 V 5 NERATINIB HUMAN UP

A Gene Set from LINCS

GSE233679 12 V 0 NICOTINAMIDE HUMAN UP

A Gene Set from LINCS

GSE195663 cisplatin 0 v 3 human up

A Gene Set from LINCS

GSE132369,GSE132371 3 V 0 CCCP HUMAN UP

A Gene Set from LINCS

GSE164874 5 V 10 PREDNISOLONE HUMAN DN

A Gene Set from LINCS

GSE120210 GSE120214 TBXT brachyury inhibition 4 v 0 human dn

A Gene Set from LINCS

GSE116810 5 V 1 SELINEXOR HUMAN UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.